Diagnostic algorithm of centrally mediated abdominal pain syndrome — does it need changes? According to the materials of Rome IV Criteria
https://doi.org/10.30629/0023-2149-2021-99-7-8-465-468
Abstract
The article discusses the algorithm for diagnosing of centrally mediated abdominal pain syndrome (CAPS), formerly called functional abdominal pain syndrome, contained in the Rome Criteria of the IV revision (2016). Recommendations for the diagnosis of CAPS, mainly based on the compliance of the signs available in patients with the developed diagnostic criteria with a minimum of additional laboratory tests, are criticized, since such an approach is fraught with possible errors. The author considers the diagnosis of CAPS as a “diagnosis of exclusion”, which can be made only after a thorough examination of patients using laboratory and instrumental research methods (including ultrasound and endoscopic), confi rming the absence of organic diseases in patients.
About the Author
A. A. Sheptulin
I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University)
Russian Federation
Russian Federation
Sheptulin Arkady Aleksandrovich
119991 Moscow
References
1. Clouse R.E., Mayer E.A., Aziz Q., Drossman D.A., Dumitrascu D.L., Mönnikes H., Naliboff B.D. Functioal abdominal pain syndrome. Gastro enterology. 2006;130(2):1492–1497. DOI: 10.1053/j.gastro.2005.11.062
2. Drossman D.A., Hasler W.L. Rome IV — Functional GI disorders: Disorders of gut-brain interaction. Gastroenterology. 2016;150(6):1257–1261. DOI: 10.1053/j.gastro.2016.03.035
3. Keefer L., Drossman D.A., Guthrie E. Simren M., Tillisch K., Olden K., Whorwell P. Centrally mediated disorders of gastrointe stinal pain. Gastroenterology. 2016;150(6):1408–1419. DOI: 10.1053/j.gastro.2016.02.034
4. Drossman D.A. Chronic abdominal pain (with emphasis on functional abdominal pain syndrome). In: Sleisenger & Fordtran’s gastrointestinal and liver disease: pathophysiology, diagnosis, management (Ed. Feldman M., Friedman L.S., Sleisenger M.H.). 7th ed., Vol. 1. Saunders. Philadelphia–London–New York–St.Louis–Sydney–Toronto. 2002:84–92.
5. Whitehead W.E., Palsson O.S., Feld A.D. et al. Utility of red fl ag symptom exclusions in the diagnosis the irritable bowel syndrome. Aliment. Pharmacol. Ther. 2006;24(1):137–146. DOI: 10.1111/j.1365-2036.2006.02956.x
6. Ford A.C., Veldhuyzen van Zanten S.J., Rodgers C.C. et al. Diagnostic utility of alarm features of colorectal cancer: systematic review and meta-anlysis. Gut. 2008;57(11):1545–1553. DOI: 10.1136/ gut.2008.159723
7. Juul J.S., Hornung B., Andersen B. et al. The value of using the faecal immunochemical test in general practice on patients presenting with non-alarm symptoms of colorectal cancer. Br. J. Cancer. 2018;119(4):471–479. DOI: 10.1038/s41416-018-0178-7
8. Göke B., Beglinger C. Gastroenterologie systematisch. 2 Aufl age. UNI-MED Verlag. Bremen–London–Bosron, 2007:469–473.
Review
For citations:
Sheptulin A.A. Diagnostic algorithm of centrally mediated abdominal pain syndrome — does it need changes? According to the materials of Rome IV Criteria. Clinical Medicine (Russian Journal). 2021;99(7-8):465-468. (In Russ.) https://doi.org/10.30629/0023-2149-2021-99-7-8-465-468
Views:
479
Email this article 